Concepedia

S Chartier

SC

5

Publications

151

Citations

5

H-Index

1993

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

S Chartier is an author at Dana-Farber Cancer Institute specializing in tumor immunity, tumor immunology, and natural killer cells.

Top concepts

Publications per year

1993–2022

5

Publications

5

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation

RJ Soiffer, R Gonin, Christine Murray et al. · Blood · 1993 · 54 citations · Full text

Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.

Robert J. Soiffer, Christine Murray, Charles M. Shapiro et al. · PubMed · 1996 · 40 citations

, , +17

Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.

Jean‐Luc Senécal, S Chartier, N Rothfield · PubMed · 1995 · 23 citations

Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation

Claudio Pignata, JS Sanghera, RJ Soiffer et al. · Blood · 1996 · 18 citations · Full text

A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

Armeen Mahvash, S Chartier, Mark Turco et al. · BMC Gastroenterology · 2022 · 16 citations · Full text

Rows per page

1–5 of 5